Cargando…
GP73 level determines chemotherapeutic resistance in human hepatocellular carcinoma cells
Objective GP73 is a new hepatocellular carcinoma (HCC) marker, which is highly expressed in hepatocellular carcinoma and closely relates to prognosis. This study was to investigate the effects of GP73 on cellular proliferation, apoptosis, oxaliplatin (OXA) resistance and secretory clusterin (sCLU) o...
Autores principales: | Ye, Jia-Zhou, Yan, Shu-mei, Yuan, Chun-ling, Wu, Hui-ni, Zhang, Jin-yan, Liu, Zhi-Hui, Li, Yong-Qiang, Luo, Xiao-Ling, Lin, Yan, Liang, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771349/ https://www.ncbi.nlm.nih.gov/pubmed/29344288 http://dx.doi.org/10.7150/jca.19185 |
Ejemplares similares
-
GP73-mediated secretion of AFP and GP73 promotes proliferation and metastasis of hepatocellular carcinoma cells
por: Liu, Yujuan, et al.
Publicado: (2021) -
Serum GP73 is complementary to AFP and GGT-II for the diagnosis of hepatocellular carcinoma
por: HOU, SI-CONG, et al.
Publicado: (2013) -
Research progress on GP73 in malignant tumors
por: Liang, Rong, et al.
Publicado: (2018) -
GP73 N-glycosylation at Asn144 reduces hepatocellular carcinoma cell motility and invasiveness
por: Jiang, Kai, et al.
Publicado: (2016) -
c-Myc transactivates GP73 and promotes metastasis of hepatocellular carcinoma cells through GP73-mediated MMP-7 trafficking in a mildly hypoxic microenvironment
por: Liu, Yiming, et al.
Publicado: (2019)